Department of Urology, Helios Hospital St. Josefshospital, Krefeld Uerdingen, Kurfuerstenstr. 69, 47829, Krefeld, Germany.
University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.
Int Urol Nephrol. 2023 Jun;55(6):1441-1446. doi: 10.1007/s11255-023-03594-1. Epub 2023 Apr 17.
INTRODUCTION/BACKGROUND: The G8 score is a widespread screening tool for geriatric frailty in oncology. The aim of this study was to evaluate the scores and relevance of G8 items in a standard screening of geriatric patients with uro-oncologic diseases to better understand the results of the assessment.
Eighty-two consecutive uro-oncologic geriatric patients aged 75 years and older were evaluated. All patients underwent a G8 screening that consisted of 8 items. Patients with a G8 score above 14 were considered geriatric "fit", while others were considered to be "frail". Overall results and single item scores were evaluated. Clinical data were gathered from patients' charts.
The mean age of the patients was 82 years (min. 75-max. 102). In 36 of the patients, the G8 score indicated "no-frailty", and in 46 patients, the G8 score indicated "frailty". The mean G8 score was 12.9 (min 4-max 17 pts). Item analysis revealed that points were most often lost in items H (polypharmacy), P (comparison of health status to peers) and Age. Fifty-nine, 56 and 52 patients lost points on item Age, item H and item P, respectively. In contrast, the majority of patients reached the maximum score for nutritional items [i.e., items A (food intake), B (weight loss) and F (body mass index (BMI))]. For item A, 73 patients reached the maximum score; for item B, 62 patients reached the maximum score; and for item F, 72 patients reached the maximum score. There were no differences in this distribution pattern when comparing tumour entities, sex, and patients with local vs. metastatic disease.
The present study revealed a high percentage of suspicious test results. Potential reasons for these findings include the low threshold of the G8 overall score and the fact that in some items, points were easily lost. Modifications of the test should be considered.
简介/背景：G8 评分是一种广泛用于肿瘤学老年虚弱的筛查工具。本研究的目的是评估 G8 评分在标准的老年泌尿科疾病患者筛查中的评分和相关性，以更好地理解评估结果。
评估了 82 例连续的 75 岁及以上的老年泌尿科肿瘤患者。所有患者均接受了包括 8 个项目的 G8 筛查。G8 评分超过 14 分的患者被认为是老年“健康”，而其他患者则被认为是“虚弱”。评估了总体结果和单项评分。临床数据来自患者的病历。
患者的平均年龄为 82 岁（最小 75 岁，最大 102 岁）。在 36 名患者中，G8 评分表明“无虚弱”，而在 46 名患者中，G8 评分表明“虚弱”。G8 评分的平均得分为 12.9（最低 4 分，最高 17 分）。项目分析显示，在 H（多药治疗）、P（与同龄人健康状况比较）和 Age 项目中，得分最常丢失。分别有 59、56 和 52 名患者在 Age、H 和 P 项目中丢失了分数。相比之下，大多数患者在营养项目[即 A（食物摄入）、B（体重减轻）和 F（体重指数（BMI））]中获得了最高分。对于项目 A，73 名患者获得了最高分；对于项目 B，62 名患者获得了最高分；对于项目 F，72 名患者获得了最高分。在比较肿瘤实体、性别以及局部和转移性疾病患者时，这种分布模式没有差异。
本研究显示可疑测试结果的比例很高。这些发现的潜在原因包括 G8 总分的低门槛以及在某些项目中很容易丢失分数。应考虑对测试进行修改。
